Phase2 Study of NT-702 in Patients With Adult Bronchial Asthma

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222058

Enrollment

Registered

2013-04-08

Start date

2013-04-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Bronchial Asthma

Interventions

investigational material(s) Generic name etc : NT-702 INN of investigational material : Therapeutic category code : 225 Bronchodilators Dosage and Administration for Investigational material : Oral

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Adult athmatics - An outpatient - Patients with mild to moderate asthma etc.

Exclusion criteria

Exclusion criteria: - An inpatient - Having critical Heart Disease, other ciruculatory disease, cerebrovascular disorder and malignancy. etc.

Design outcomes

Primary

Measure	Time frame
efficacy (pulmonary function test)	—

Secondary

Measure	Time frame
efficacy (clinical condition etc.)	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026